Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Xenova reports on PAI inhibitor R&D

July 5, 1996

Role of adhesion molecules in hemostasis

July 5, 1996

Excellent antiplatelet activity seen with (R)-(-)-NSP-307

July 5, 1996

FK-633 in phase II trials

June 28, 1996

Fibrinogen antagonists in Terumo's pipeline

June 28, 1996

Neutralase covered under Japanese patent

June 28, 1996

Texas Biotechnology and Synthelabo enter new argatroban collaboration

June 28, 1996

BCH-2763: BioChem Therapeutic's novel thrombin inhibitor

June 28, 1996

Nippon Mining reports on HV1C3

June 28, 1996

FDA approval of new indication for Genentech's Activase

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...